Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$67.52 - $89.42 $46,656 - $61,789
691 New
691 $47,000
Q4 2022

Feb 13, 2023

BUY
$80.67 - $352.29 $59,211 - $258,580
734 Added 209.71%
1,084 $89,000
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $112,934 - $157,377
350 New
350 $121,000
Q1 2022

May 13, 2022

SELL
$353.85 - $487.79 $135,170 - $186,335
-382 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $41,053 - $47,255
90 Added 30.82%
382 $198,000
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $3.1 Million - $3.75 Million
-6,965 Reduced 95.98%
292 $141,000
Q2 2021

Aug 16, 2021

SELL
$387.35 - $450.26 $4.02 Million - $4.67 Million
-10,373 Reduced 58.84%
7,257 $3.27 Million
Q1 2021

May 13, 2021

BUY
$314.62 - $411.0 $3.08 Million - $4.02 Million
9,779 Added 124.56%
17,630 $6.73 Million
Q4 2020

Feb 12, 2021

SELL
$246.9 - $321.87 $124,684 - $162,544
-505 Reduced 6.04%
7,851 $2.49 Million
Q3 2020

Nov 12, 2020

SELL
$232.22 - $282.96 $197,154 - $240,233
-849 Reduced 9.22%
8,356 $2.07 Million
Q2 2020

Aug 13, 2020

SELL
$185.43 - $279.56 $174,304 - $262,786
-940 Reduced 9.27%
9,205 $2.43 Million
Q1 2020

May 13, 2020

SELL
$161.17 - $221.51 $90,416 - $124,267
-561 Reduced 5.24%
10,145 $1.92 Million
Q4 2019

Feb 14, 2020

SELL
$189.68 - $222.09 $176,212 - $206,321
-929 Reduced 7.98%
10,706 $2.35 Million
Q3 2019

Nov 14, 2019

SELL
$183.56 - $216.72 $355,922 - $420,220
-1,939 Reduced 14.28%
11,635 $2.28 Million
Q2 2019

Aug 14, 2019

BUY
$188.72 - $215.43 $199,477 - $227,709
1,057 Added 8.44%
13,574 $2.83 Million
Q1 2019

May 10, 2019

SELL
$136.09 - $200.44 $78,932 - $116,255
-580 Reduced 4.43%
12,517 $2.49 Million
Q4 2018

Feb 13, 2019

SELL
$132.75 - $203.8 $413,383 - $634,633
-3,114 Reduced 19.21%
13,097 $1.9 Million
Q3 2018

Nov 13, 2018

SELL
$147.44 - $204.11 $123,407 - $170,840
-837 Reduced 4.91%
16,211 $3.31 Million
Q2 2018

Aug 10, 2018

BUY
$144.9 - $165.58 $230,101 - $262,941
1,588 Added 10.27%
17,048 $2.52 Million
Q1 2018

May 09, 2018

BUY
$131.46 - $151.04 $67,044 - $77,030
510 Added 3.41%
15,460 $2.34 Million
Q4 2017

Feb 14, 2018

SELL
$121.17 - $134.75 $275,904 - $306,825
-2,277 Reduced 13.22%
14,950 $0
Q3 2017

Nov 13, 2017

BUY
$113.59 - $123.78 $1.96 Million - $2.13 Million
17,227
17,227 $2.08 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.4B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.